Loading provider…
Loading provider…
Hematology & Oncology Physician in Meridian, ID
NPI: 1023093507Primary Practice Location
ST LUKE'S ELMORE MEDICAL CENTER
895 N 6th E, Mountain Home, ID
Primary Employer
St Lukes Clinic-Treasure Valley LLC
stlukesonline.org
HQ Phone
Get MD Dan's Phone Numberphone_androidMobile
Get MD Dan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardID State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 129 | 405 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 107 | 145 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 52 | 106 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 21 | 21 |
Authors: James Cleary, Thomas Abrams, Kimmie Ng, Douglas Weckstein, Chryssanthi Kournioti, Christian Thomas, Deborah Schrag, Emily Chan, Charles Fuchs, Jennifer Chan, Meredith Faggen
Journal: JAMA
Authors: James Cleary, Thomas Abrams, Kimmie Ng, Douglas Weckstein, Chryssanthi Kournioti, Christian Thomas, Deborah Schrag, Justin Chatten Brown, Emily Chan, Charles Fuchs, Meredith Faggen
Journal: Cancers (Basel)
Publication Date: 2020-11-20
Authors: Paolo Tarantino, Ron Bose, Antonio Wolff, Steven Isakoff, Lowell Hart, Douglas Weckstein, Mothaffar Rimawi, Frederick Briccetti, Therese Mulvey, Blair Ardman, Rita Nanda, Rachel Jankowitz, Andres Forero-Torres, Richard Gelber, Paula Pohlmann, Kit Cheng, Ian Krop, Vandana Abramson, Bryan Schneider
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, PROCEDURE: Positron Emission Tomography, BIOLOGICAL: Bevacizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Oxaliplatin, DRUG: Leucovorin
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, RADIATION: External Beam Radiation Therapy, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, RADIATION: Brachytherapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, PROCEDURE: Biopsy Procedure, RADIATION: Image Guided Radiation Therapy
Journal: NPJ Breast Cancer
Publication Date: 2022-02-16